CCR9 and Familial prostate cancer: Recent data have shown that CCR9 is functionally and significantly expressed in various cancers, such as acute lymphocytic leukemia [16], melanoma [17], prostate cancer [18], pancreatic cancer [19], breast cancer [20], ovarian cancer [21] and colon cancer [22].